Home » IPCA, CDRI to Develop Anti-Malarial Drugs Based on Artemisinin
IPCA, CDRI to Develop Anti-Malarial Drugs Based on Artemisinin
Drug maker IPCA Laboratories said together with Central Drug Research Institute (CDRI) it will develop a synthetic substitute of anti-malarial drugs, based on Artemisinin.
The Economic Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May